Boston Scientific Corporation
BSX
株式のランク
#409
この企業概要は英語でのみ提供されています。
Boston Scientific Corporation (BSX) operates as a global leader in medical... Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovations include drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.
株価
$41.88
最終同期: 2026-10-30
時価総額
$60.69B
変化（1日）
-1.89%
変化（1年）
-58.42%
国
US
株式データ: Financial Modeling Prep·更新日: ·投資助言ではありません·計算方法
取引 Boston Scientific Corporation (BSX)
カテゴリー
Healthcare
Boston Scientific Corporation（BSX）の株式分割履歴
Boston Scientific Corporation株（シンボル：BSX）は合計で2回の株式分割を実施しました。
最新の株式分割はNov 06, 2003に行われました。
Dec 01, 1998より前に購入されたBSX株は、現在4BSX株に相当します。
最新の株式分割はNov 06, 2003に行われました。
Dec 01, 1998より前に購入されたBSX株は、現在4BSX株に相当します。
株式分割一覧
| 年 | 株式分割 | 分割比率 | 累積分割比率 |
|---|---|---|---|
| 2003-11-06 | 2:1 | x2 | x4 |
| 1998-12-01 | 2:1 | x2 | x2 |
類似企業または競合他社の株式分割
| 企業 | 株式分割の回数 | 累積分割比率 | 国 |
|---|---|---|---|
| 9 | x285 |
US
|
|
| 7 | x127 |
IE
|
|
| 9 | x162 |
US
|
|
| 0 | - |
DE
|
|
| 3 | x12 |
US
|
Boston Scientific Corporationの株式分割に関する質問
Boston Scientific Corporationはこれまでに何回株式分割を行っていますか？
Boston Scientific Corporation（BSX）はこれまでに2回の株式分割を行っています。最初の分割は1998/12/01、直近の分割は2003/11/06です。
1998/12/01より前に買ったBoston Scientific Corporationの株1株は、現在何株になっていますか？
すべての株式分割を反映すると、1998/12/01より前に買った1株は現在4.00株になります。